Search research articles
Contact Us
Filters
Showing results (111-120 of 198) with videos related to
Page
of 20
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
September 30, 2004
A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis
Dearg S Brown, Andrew J Belfield, George R Brown, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 30, 2024
Real-World Use of Hypofractionated Radiotherapy for Primary CNS Tumors in the Elderly, and Implications on Medicare Spending
Kathryn R Tringale, Andrew Lin, Alexandra M Miller, et al.
The Biochemical Journal
|
October 20, 2012
Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival
Luke R G Pike, Dean C Singleton, Francesca Buffa, et al.
Journal of Neuro-Oncology
|
November 18, 2025
Clinical and genomic characterization of brain metastasis in thyroid cancer
Branavan Manoranjan, Sabrina Zeller, Zelalem Demere, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 29, 2021
Microstructural Abnormalities of the Dentatorubrothalamic Tract in Cervical Dystonia
Rachel E Sondergaard, Conrad P Rockel, Filomeno Cortese, et al.
British Journal of Pharmacology
|
August 22, 2006
Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats
G J Coope, A M Atkinson, C Allott, et al.
Plos One
|
December 27, 2018
Leprosy at the edge of Europe-Biomolecular, isotopic and osteoarchaeological findings from medieval Ireland
G Michael Taylor, Eileen M Murphy, Tom A Mendum, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2013
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014
Kurt G Pike, Karine Malagu, Marc G Hummersone, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases
Dearg S Brown, John G Cumming, Paul Bethel, et al.
Journal of Neuro-Oncology
|
May 18, 2026
Care pathways for asymptomatic brain metastases: comparison of healthcare utilization, costs, and outcomes in outpatient versus acute settings
Matthew Wierzbicki, Stephen G Bowden, Stephanie M Robert, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 198) with videos related to
Sort By:
Page
of 20
Bioorganic & Medicinal Chemistry Letters
|
September 30, 2004
A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis
Dearg S Brown, Andrew J Belfield, George R Brown, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 30, 2024
Real-World Use of Hypofractionated Radiotherapy for Primary CNS Tumors in the Elderly, and Implications on Medicare Spending
Kathryn R Tringale, Andrew Lin, Alexandra M Miller, et al.
The Biochemical Journal
|
October 20, 2012
Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival
Luke R G Pike, Dean C Singleton, Francesca Buffa, et al.
Journal of Neuro-Oncology
|
November 18, 2025
Clinical and genomic characterization of brain metastasis in thyroid cancer
Branavan Manoranjan, Sabrina Zeller, Zelalem Demere, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 29, 2021
Microstructural Abnormalities of the Dentatorubrothalamic Tract in Cervical Dystonia
Rachel E Sondergaard, Conrad P Rockel, Filomeno Cortese, et al.
British Journal of Pharmacology
|
August 22, 2006
Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats
G J Coope, A M Atkinson, C Allott, et al.
Plos One
|
December 27, 2018
Leprosy at the edge of Europe-Biomolecular, isotopic and osteoarchaeological findings from medieval Ireland
G Michael Taylor, Eileen M Murphy, Tom A Mendum, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2013
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014
Kurt G Pike, Karine Malagu, Marc G Hummersone, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 22, 2012
The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases
Dearg S Brown, John G Cumming, Paul Bethel, et al.
Journal of Neuro-Oncology
|
May 18, 2026
Care pathways for asymptomatic brain metastases: comparison of healthcare utilization, costs, and outcomes in outpatient versus acute settings
Matthew Wierzbicki, Stephen G Bowden, Stephanie M Robert, et al.
Page
of 20